Latest

Opinion

Commercial

Evidence

  • The next generation of personalized oncology in the US

    eyeforpharma Ed..., (Oct 15, 2014)

    Listen to Laura Housman, Chief Commercial Officera at Molecular Health, and Stan Skrzypczak, Vice President of Business Development at InVitae, share their years of experience in the field to deliver a roadmap to the reimbursement landscape for advanced next-generation sequencing in oncology, and explain how to guarantee that your diagnostic tests evolve with and ahead of dynamic clinical advances

Clinical

May

June